Medical news
-
WBDR reaches important milestones
The World Bleeding Disorders Registry (WBDR) provides a global platform for hemophilia treatment centres (HTCs) to collect standardized data on people with hemophilia. The WFH...
-
New gene therapy CME activity: The Science of Gene Therapy for Hemophilia
The World Federation of Hemophilia (WFH) is proud to announce the launch of the next activity in Clinical Advances in Gene Therapy for Hemophilia, an...
-
WFH WBDR Research Support Program announced
The World Federation of Hemophilia (WFH) is pleased to announce the launch of the WFH World Bleeding Disorders Registry (WBDR) Research Support Program. The WBDR...
-
New gene therapy CME program launched
The World Federation of Hemophilia (WFH) is proud to announce the launch of Clinical Advances in Gene Therapy for Hemophilia, an online continuing medical education...
-
VWD Guidelines development—add your voice
As recently announced, the World Federation of Hemophilia (WFH) has joined a collaboration led by the American Society of Hematology (ASH), which also includes the...
-
ASH WFH ISTH NHF VWD Guidelines – an international collaboration
The World Federation of Hemophilia (WFH) has joined a collaboration led by the American Society of Hematology (ASH), which also includes the International Society on...
-
Alert on the use of vials of water for injection (2.5ml, 5ml and 10ml) included in some LFB BIOMEDICAMENTS products
Please note that LFB BIOMEDICAMENTS has issued an alert concerning a defect in the quality appearance of the water for injection (vials 2.5ml, 5ml and...
-
From protocols to demo videos: the WFH Laboratory Manual on the eLearning Platform
The World Federation of Hemophilia (WFH) is pleased to showcase the Diagnosis of Hemophilia and Other Bleeding Disorders: A Laboratory Manual, the definitive how-to guide...
-
WFH World Bleeding Disorders Registry kick-off webinar and live training opportunities
On December 12, 2017, the WFH hosted a webinar for people across the globe interested in learning more about participating in the WFH World Bleeding...
-
First case of an anti-drug antibody reported in Hemlibra trial
Roche has reported that a young patient in the HAVEN 2 clinical trial for Hemlibra (emicizumab) has developed an anti-drug antibody to Hemlibra resulting in...
